Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies
SHANGHAI, April 10, 2026 /PRNewswire/ -- Oricell Therapeutics Holdings Limited ("Oricell"), a global clinical-stage biotechnology company pioneering innovative cancer immunotherapies, today announced the cumulative closing of a pre-IPO financing...
HR Asia Recognises Companies Leading Asia's Workplace Transformation
SINGAPORE, Jan. 12, 2026 /PRNewswire/ -- Organized by Business Media International, the HR Asia Best Companies to Work for in Asia recognised outstanding companies that have demonstrated resilience, adaptability and commitment to people-first...